BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8932263)

  • 1. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients.
    Flechner SM; Modlin CS; Serrano DP; Goldfarb DA; Papajcik D; Mastroianni B; Goormastic M; Novick AC
    Transplantation; 1996 Nov; 62(9):1235-41. PubMed ID: 8932263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients.
    Goel M; Flechner SM; Ischikawa A; Induhara R; Mastroianni B; Savas K; Modlin C; Goldfarb D; Feng J; Cook DJ; Novick AC
    Clin Transplant; 2002 Dec; 16(6):442-9. PubMed ID: 12437625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for chronic rejection in renal allograft recipients.
    Almond PS; Matas A; Gillingham K; Dunn DL; Payne WD; Gores P; Gruessner R; Najarian JS
    Transplantation; 1993 Apr; 55(4):752-6; discussion 756-7. PubMed ID: 8475548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation.
    Knight RJ; Burrows L; Bodian C
    Transplantation; 2001 Jul; 72(1):69-76. PubMed ID: 11468537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causes of long-term graft failure in renal transplantation.
    Tanabe K; Takahashi K; Toma H
    World J Urol; 1996; 14(4):230-5. PubMed ID: 8873436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of late acute rejection after cadaveric kidney transplantation.
    Joseph JT; Kingsmore DB; Junor BJ; Briggs JD; Mun Woo Y; Jaques BC; Hamilton DN; Jardine AG; Jindal RM
    Clin Transplant; 2001 Aug; 15(4):221-7. PubMed ID: 11683814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
    Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
    Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients.
    Madden RL; Mulhern JG; Benedetto BJ; O'Shea MH; Germain MJ; Braden GL; O'Shaughnessy J; Lipkowitz GS
    Transpl Int; 2000; 13(5):344-50. PubMed ID: 11052270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants.
    Gulanikar AC; MacDonald AS; Sungurtekin U; Belitsky P
    Transplantation; 1992 Feb; 53(2):323-8. PubMed ID: 1738926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens.
    Lindholm A; Ohlman S; Albrechtsen D; Tufveson G; Persson H; Persson NH
    Transplantation; 1993 Aug; 56(2):307-15. PubMed ID: 8356584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early versus late acute renal allograft rejection: impact on chronic rejection.
    Basadonna GP; Matas AJ; Gillingham KJ; Payne WD; Dunn DL; Sutherland DE; Gores PF; Gruessner RW; Najarian JS
    Transplantation; 1993 May; 55(5):993-5. PubMed ID: 8497913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.